JENNIFER ALFRED: Open Payments
NPI 1437931748 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 50 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $245 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $279 |
| Otsuka America Pharmaceutical, Inc. | 5 | $128 |
| Lilly USA, LLC | 4 | $98 |
| Lundbeck LLC | 4 | $90 |
| Neurocrine BioSciences, Inc. | 3 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Viatris Specialty LLC | 2 | $51 |
| Ardelyx, Inc. | 2 | $50 |
| PFIZER INC. | 2 | $47 |
Products named: REXULTI, UBRELVY, VRAYLAR, INGREZZA, QULIPTA, Kerendia, KISUNLA, CAPLYTA.
Industry payments across RI — which companies pay providers there.
